menieres-pic.ppt

Embed Size (px)

Citation preview

  • 7/29/2019 menieres-pic.ppt

    1/39

    Menieres Disease

    Samuel Ross Patton, MD

    Tomoko Makishima, MD, PhD

    Dayton Young, MD

    The University of Texas Medical Branch

    (UTMB Health)

    Department of OtolaryngologyGrand Rounds Presentation

    May 29, 2012

  • 7/29/2019 menieres-pic.ppt

    2/39

    Introduction

    hydrops

    normal

  • 7/29/2019 menieres-pic.ppt

    3/39

    Prosper Meniere

    1861

    History

  • 7/29/2019 menieres-pic.ppt

    4/39

    Demographics

    Incidence: 17/100,000 (Japan)- 5/1000 (Denmark)

    Peak Onset: 4th and 5th decade

  • 7/29/2019 menieres-pic.ppt

    5/39

    Presentation

  • 7/29/2019 menieres-pic.ppt

    6/39

    Presentation

  • 7/29/2019 menieres-pic.ppt

    7/39

    Presentation

  • 7/29/2019 menieres-pic.ppt

    8/39

    Presentation

  • 7/29/2019 menieres-pic.ppt

    9/39

    Pathophysiology

  • 7/29/2019 menieres-pic.ppt

    10/39

    Pathophysiology

  • 7/29/2019 menieres-pic.ppt

    11/39

    Possible Mechanisms

    Auto-immune

    virus

    ischemic

  • 7/29/2019 menieres-pic.ppt

    12/39

    Schuknecht theory

  • 7/29/2019 menieres-pic.ppt

    13/39

    Problems with Theory

    Merchant Study:

    -25 of idiopathic hydrops with no symptoms

  • 7/29/2019 menieres-pic.ppt

    14/39

  • 7/29/2019 menieres-pic.ppt

    15/39

    Natural History

    Silverstein Study

    8 years

    71%

    +

    10% well controlled

  • 7/29/2019 menieres-pic.ppt

    16/39

    Diagnosis

    History Physical Exam

    Audiogram

    VEMPs

    ECoG

    VNG

    Blood tests

    MRI

  • 7/29/2019 menieres-pic.ppt

    17/39

    ECoG

  • 7/29/2019 menieres-pic.ppt

    18/39

    ECoG

  • 7/29/2019 menieres-pic.ppt

    19/39

    ECoG

  • 7/29/2019 menieres-pic.ppt

    20/39

    ECoG

  • 7/29/2019 menieres-pic.ppt

    21/39

    ECoG

  • 7/29/2019 menieres-pic.ppt

    22/39

    VEMPs

  • 7/29/2019 menieres-pic.ppt

    23/39

    Classification

  • 7/29/2019 menieres-pic.ppt

    24/39

    Classification

  • 7/29/2019 menieres-pic.ppt

    25/39

    Treatments

  • 7/29/2019 menieres-pic.ppt

    26/39

    Labyrinthectomy

    -Selective nerve sectioning

    -Intra-tympanic gentimicin

    -Endolympatic sac decompression

    -Diuretics

    -Low Na Diet

    -steroids(oral or IT)

    Conservative/Medical Treatment

    Non-ablative procedures

    Non-surgical ablative procedures

    Ablative Surgical Procedures

  • 7/29/2019 menieres-pic.ppt

    27/39

    Medical Therapy

  • 7/29/2019 menieres-pic.ppt

    28/39

    Diuretics

    Cochrane

    Review:

  • 7/29/2019 menieres-pic.ppt

    29/39

    Medical Therapy

    Steroids

    90%

  • 7/29/2019 menieres-pic.ppt

    30/39

    Labyrinthectomy

    -Selective nerve sectioning

    -Intra-tympanic gentimicin

    -Endolympatic sac decompression

    -Diuretics

    -Low Na Diet

    -steroids(oral or IT)

    Conservative/Medical Treatment

    Non-ablative procedures

    Non-surgical ablative procedures

    Ablative Surgical Procedures

  • 7/29/2019 menieres-pic.ppt

    31/39

    Endolymphatic Sac Surgery

  • 7/29/2019 menieres-pic.ppt

    32/39

    Labyrinthectomy

    -Selective nerve sectioning

    -Intra-tympanic gentimicin

    -Endolympatic sac decompression

    -Diuretics

    -Low Na Diet

    -steroids(oral or IT)

    Conservative/Medical Treatment

    Non-ablative procedures

    Non-surgical ablative procedures

    Ablative Surgical Procedures

  • 7/29/2019 menieres-pic.ppt

    33/39

    Intratympanic Gentamicin

  • 7/29/2019 menieres-pic.ppt

    34/39

    Labyrinthectomy

    -Selective nerve sectioning

    -Intra-tympanic gentimicin

    -Endolympatic sac decompression

    -Diuretics

    -Low Na Diet

    -steroids(oral or IT)

    Conservative/Medical Treatment

    Non-ablative procedures

    Non-surgical ablative procedures

    Ablative Surgical Procedures

  • 7/29/2019 menieres-pic.ppt

    35/39

    Vestibular Nerve Section

  • 7/29/2019 menieres-pic.ppt

    36/39

    Labyrinthectomy

    -Selective nerve sectioning

    -Intra-tympanic gentimicin

    -Endolympatic sac decompression

    -Diuretics

    -Low Na Diet

    -steroids(oral or IT)

    Conservative/Medical Treatment

    Non-ablative procedures

    Non-surgical ablative procedures

    Ablative Surgical Procedures

  • 7/29/2019 menieres-pic.ppt

    37/39

    Labyrinthectomy

    References

  • 7/29/2019 menieres-pic.ppt

    38/39

    e e e ces

    1Baloh RW. Prosper Meniere and His Disease. Arch Neurol. 2001;58:1151-11562. Boleas-Aguirre MS, Lin FR, Della Santina CC, et al. Longitudinal results with intratympanic dexamethasone in the treatment of Menieres disease.

    Otol Neurotol 2008;29:33

    3. Burgess A, Kundu S. Diuretics for Mnires disease or syndrome. Cochrane Database of Systematic Reviews. 2006;3:CD003599.

    4. Chia SH. Gamst AC. Anderson JP. Harris JP. Intratympanic Gentamicin Therapy for Menieres Disease: A Meta-analysis. Otology &Neurotology. 2004;25:544-552.

    5. Crane BT. Schessel DA. Nedzelski J. Minor LB. Peripheral Vestibular Disorders. Otolaryngology Head & Neck Surgery. 5th Edition. 2328-

    2345.

    6. Diaz RC. LaRouere MJ. Bojrab DI. Zappia JJ. Sargent EW. Shaia WT. Quality-of-Life Assessment of Menieres Disease Patients After

    Surgical

    Labyrinthectomy. Otology & Neurotology. 2006;28:74-76

    7. Merchant SN. Adams JC. Nadol JB. Pathophysiology of Menieres Syndrome: Are Symptoms Caused by Endolymphatic Hydrops? Otology &

    Neurotology. 2005;26:74-81.8. . Ferraro JA. Arenberg IK. Hassanein RS. Electrocochleography and Symptoms of Inner Ear Dysfunction. Arch Otolaryngology. 1985;111:71-

    74.

    9. Ferraro JA. Durrant JD. Electrocochleography in the Evaluation of Patients with Menieres Disease/Endolymphatic Hydrops. J Am Acad Audiol

    17:4568 (2006).

    10. Nguyen CD. Brackmann DE. Crane RT. Linthicum FH. Hitselberger WE. Retrolabyrinthine Vestibular Nerve Section: Evaluation of Technical

    Modification in 143 Cases. American Journal of Otology: 1992;13;4:328-332

    11. Pou AM. Hirsch BE, Durrant JD, Gold SR, Kamerer DB. The Efficacy of Tympanic Electrocochleography in the Diagnosis of Endolymphatic

    Hydrops. The American Journal of Otology. 1996;16:607-611

    12. Quaranta A. Marini F. Sallustio V. Long-term Outcome of Menieres Disease: Endolymphatic Mastoid Shunt vs Natural History. AudiolNeurootol.

    1998;3:54-60.

    13. Rauch SD. Zhou G. Kujawa SG. Guinan JJ. Herrmann BS. Vestibular Evoked Myogenic Potentials Show Altered Tuning in Patients with

    Menieres Disease. Otology & Neurotology. 2004;25:333-338.

    14. Rosenberg SI. Silverstein H. Hoffer ME. Thaler E. Hearing Results After Posterior Fossa Vestibular Neurectomy. Otolaryngology Head Neck

    Surg. 1996;114:32-7

  • 7/29/2019 menieres-pic.ppt

    39/39

    References

    15. Semaan MT, Megerian CA. Menieres Disease: A Challenging and Relentless Disorder.

    Otolaryngol Clin N Am 44 (2011) 383403.

    16. Silverstein, H. Smouha E. Jones R. Natural History vs Surgery for Menieres Disease. Otolaryngol Head Neck Surg. 1989100;6.

    17. Telischi FF. Luxford WM. Long-Term efficacy of Endolymphatic Sac Surgery for Vertigo in Menieres Disease. Otolaryngology- Head and Neck

    Surgery. 1993:109;1:83-7.

    18. Timmer FCA. Zhou G. Guinan JJ. Kujawa SG. Herrmann BS. Rauch SD. Vestibular Evoked Myogenic Potential in Patients with Menieres

    Disease with Drop Attacks. The Laryngoscope. 2006;116;776-779.